{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T12:32:21Z","timestamp":1782477141852,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,11,29]],"date-time":"2016-11-29T00:00:00Z","timestamp":1480377600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s00259-016-3586-z","type":"journal-article","created":{"date-parts":[[2016,11,29]],"date-time":"2016-11-29T06:37:37Z","timestamp":1480401457000},"page":"812-821","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["18F-fluorodihydroxyphenylalanine PET\/CT in pheochromocytoma and paraganglioma: relation to genotype and amino acid transport system L"],"prefix":"10.1007","volume":"44","author":[{"given":"Chlo\u00e9 C.","family":"Feral","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floriane S.","family":"Tissot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Tosello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Fakhry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9deric","family":"Sebag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Pacak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ta\u00efeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,29]]},"reference":[{"key":"3586_CR1","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.neo.2014.10.010","volume":"17","author":"A Imperiale","year":"2015","unstructured":"Imperiale A, Moussallieh FM, Roche P, Battini S, Cicek AE, Sebag F, et al. Metabolome Profiling by HRMAS NMR Spectroscopy of Pheochromocytomas and Paragangliomas Detects SDH Deficiency: Clinical and Pathophysiological Implications. Neoplasia. 2015;17:55\u201365. doi: 10.1016\/j.neo.2014.10.010 .","journal-title":"Neoplasia"},{"key":"3586_CR2","doi-asserted-by":"publisher","first-page":"e80539","DOI":"10.1371\/journal.pone.0080539","volume":"8","author":"A Imperiale","year":"2013","unstructured":"Imperiale A, Moussallieh FM, Sebag F, Brunaud L, Barlier A, Elbayed K, et al. A new specific succinate-glutamate metabolomic hallmark in SDHx-related paragangliomas. PLoS One. 2013;8:e80539. doi: 10.1371\/journal.pone.0080539 .","journal-title":"PLoS One"},{"key":"3586_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1210\/en.2013-1549","volume":"155","author":"N Lendvai","year":"2014","unstructured":"Lendvai N, Pawlosky R, Bullova P, Eisenhofer G, Patocs A, Veech RL, et al. Succinate-to-fumarate ratio as a new metabolic marker to detect the presence of SDHB\/D-related paraganglioma: initial experimental and ex vivo findings. Endocrinology. 2014;155:27\u201332. doi: 10.1210\/en.2013-1549 .","journal-title":"Endocrinology"},{"key":"3586_CR4","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.1210\/jc.2014-2151","volume":"99","author":"S Richter","year":"2014","unstructured":"Richter S, Peitzsch M, Rapizzi E, Lenders JW, Qin N, de Cubas AA, et al. Krebs cycle metabolite profiling for identification and stratification of pheochromocytomas\/paragangliomas due to succinate dehydrogenase deficiency. J Clin Endocrinol Metab. 2014;99:3903\u201311. doi: 10.1210\/jc.2014-2151 .","journal-title":"J Clin Endocrinol Metab"},{"key":"3586_CR5","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1210\/jc.2009-1248","volume":"94","author":"HJ Timmers","year":"2009","unstructured":"Timmers HJ, Chen CC, Carrasquillo JA, Whatley M, Ling A, Havekes B, et al. Comparison of 18F-Fluoro-L-DOPA, 18F-Fluoro-Deoxyglucose, and 18F-Fluorodopamine PET and 123I-MIBG Scintigraphy in the Localization of Pheochromocytoma and Paraganglioma. J Clin Endocrinol Metab. 2009;94:4757\u201367.","journal-title":"J Clin Endocrinol Metab"},{"key":"3586_CR6","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1093\/jnci\/djs188","volume":"104","author":"HJ Timmers","year":"2012","unstructured":"Timmers HJ, Chen CC, Carrasquillo JA, Whatley M, Ling A, Eisenhofer G, et al. Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography. J Natl Cancer Inst. 2012;104:700\u20138. doi: 10.1093\/jnci\/djs188 .","journal-title":"J Natl Cancer Inst"},{"key":"3586_CR7","doi-asserted-by":"publisher","first-page":"711","DOI":"10.2967\/jnumed.108.060731","volume":"50","author":"D Taieb","year":"2009","unstructured":"Taieb D, Sebag F, Barlier A, Tessonnier L, Palazzo FF, Morange I, et al. 18F-FDG avidity of pheochromocytomas and paragangliomas: a new molecular imaging signature? J Nucl Med. 2009;50:711\u20137. doi: 10.2967\/jnumed.108.060731 .","journal-title":"J Nucl Med"},{"key":"3586_CR8","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1007\/s00259-012-2087-y","volume":"39","author":"G Treglia","year":"2012","unstructured":"Treglia G, Cocciolillo F, de Waure C, Di Nardo F, Gualano MR, Castaldi P, et al. Diagnostic performance of 18F-dihydroxyphenylalanine positron emission tomography in patients with paraganglioma: a meta-analysis. Eur J Nucl Med Mol Imaging. 2012;39:1144\u201353. doi: 10.1007\/s00259-012-2087-y .","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3586_CR9","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/cen.12126","volume":"79","author":"S Gabriel","year":"2013","unstructured":"Gabriel S, Blanchet EM, Sebag F, Chen CC, Fakhry N, Deveze A, et al. Functional characterization of nonmetastatic paraganglioma and pheochromocytoma by (18) F-FDOPA PET: focus on missed lesions. Clin Endocrinol. 2013;79:170\u20137. doi: 10.1111\/cen.12126 .","journal-title":"Clin Endocrinol"},{"key":"3586_CR10","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.2967\/jnumed.107.043620","volume":"48","author":"C Haase","year":"2007","unstructured":"Haase C, Bergmann R, Fuechtner F, Hoepping A, Pietzsch J. L-type amino acid transporters LAT1 and LAT4 in cancer: uptake of 3-O-methyl-6-18F-fluoro-L-dopa in human adenocarcinoma and squamous cell carcinoma in vitro and in vivo. J Nucl Med. 2007;48:2063\u201371. doi: 10.2967\/jnumed.107.043620 .","journal-title":"J Nucl Med"},{"key":"3586_CR11","doi-asserted-by":"publisher","first-page":"30411","DOI":"10.1074\/jbc.M113.490698","volume":"288","author":"SR Beyer","year":"2013","unstructured":"Beyer SR, Mallmann RT, Jaenecke I, Habermeier A, Boissel JP, Closs EI. Identification of cysteine residues in human cationic amino acid transporter hCAT-2A that are targets for inhibition by N-ethylmaleimide. J Biol Chem. 2013;288:30411\u20139. doi: 10.1074\/jbc.M113.490698 .","journal-title":"J Biol Chem"},{"key":"3586_CR12","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s00259-016-3354-0","volume":"43","author":"D Taieb","year":"2016","unstructured":"Taieb D, Imperiale A, Pacak K. (18)F-DOPA: the versatile radiopharmaceutical. Eur J Nucl Med Mol Imaging. 2016;43:1187\u20139. doi: 10.1007\/s00259-016-3354-0 .","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3586_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-015-3268-2","author":"A Archier","year":"2015","unstructured":"Archier A, Varoquaux A, Garrigue P, Montava M, Guerin C, Gabriel S, et al. Prospective comparison of Ga-DOTATATE and F-FDOPA PET\/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases. Eur J Nucl Med Mol Imaging. 2015. doi: 10.1007\/s00259-015-3268-2 .","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3586_CR14","doi-asserted-by":"publisher","first-page":"e0157139","DOI":"10.1371\/journal.pone.0157139","volume":"11","author":"C Papin-Michault","year":"2016","unstructured":"Papin-Michault C, Bonnetaud C, Dufour M, Almairac F, Coutts M, Patouraux S, et al. Study of LAT1 expression in brain metastases: towards a better understanding of the results of positron emission tomography using amino acid tracers. PLoS One. 2016;11:e0157139. doi: 10.1371\/journal.pone.0157139 .","journal-title":"PLoS One"},{"key":"3586_CR15","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1152\/physrev.00018.2006","volume":"88","author":"S Broer","year":"2008","unstructured":"Broer S. Amino acid transport across mammalian intestinal and renal epithelia. Physiol Rev. 2008;88:249\u201386. doi: 10.1152\/physrev.00018.2006 .","journal-title":"Physiol Rev"},{"key":"3586_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj20030405","volume":"373","author":"R Hyde","year":"2003","unstructured":"Hyde R, Taylor PM, Hundal HS. Amino acid transporters: roles in amino acid sensing and signalling in animal cells. Biochem J. 2003;373:1\u201318.","journal-title":"Biochem J"},{"key":"3586_CR17","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.mam.2012.07.012","volume":"34","author":"HB Schioth","year":"2013","unstructured":"Schioth HB, Roshanbin S, Hagglund MG, Fredriksson R. Evolutionary origin of amino acid transporter families SLC32, SLC36 and SLC38 and physiological, pathological and therapeutic aspects. Mol Asp Med. 2013;34:571\u201385. doi: 10.1016\/j.mam.2012.07.012 .","journal-title":"Mol Asp Med"},{"key":"3586_CR18","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1042\/BJ20111484","volume":"439","author":"S Broer","year":"2011","unstructured":"Broer S. Targeting tumour cells at the entrance. Biochem J. 2011;439:e1\u20132. doi: 10.1042\/BJ20111484 .","journal-title":"Biochem J"},{"key":"3586_CR19","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1042\/BJ20101912","volume":"436","author":"S Broer","year":"2011","unstructured":"Broer S, Palacin M. The role of amino acid transporters in inherited and acquired diseases. Biochem J. 2011;436:193\u2013211. doi: 10.1042\/BJ20101912 .","journal-title":"Biochem J"},{"key":"3586_CR20","doi-asserted-by":"publisher","first-page":"e0156044","DOI":"10.1371\/journal.pone.0156044","volume":"11","author":"S Barollo","year":"2016","unstructured":"Barollo S, Bertazza L, Watutantrige-Fernando S, Censi S, Cavedon E, Galuppini F, et al. Overexpression of L-type amino acid transporter 1 (LAT1) and 2 (LAT2): novel markers of neuroendocrine tumors. PLoS One. 2016;11:e0156044. doi: 10.1371\/journal.pone.0156044 .","journal-title":"PLoS One"},{"key":"3586_CR21","doi-asserted-by":"publisher","first-page":"8784","DOI":"10.1038\/ncomms9784","volume":"6","author":"C Lussey-Lepoutre","year":"2015","unstructured":"Lussey-Lepoutre C, Hollinshead KE, Ludwig C, Menara M, Morin A, Castro-Vega LJ, et al. Loss of succinate dehydrogenase activity results in dependency on pyruvate carboxylation for cellular anabolism. Nat Commun. 2015;6:8784. doi: 10.1038\/ncomms9784 .","journal-title":"Nat Commun"},{"key":"3586_CR22","doi-asserted-by":"publisher","first-page":"F252","DOI":"10.1152\/ajprenal.00030.2004","volume":"287","author":"P Soares-da-Silva","year":"2004","unstructured":"Soares-da-Silva P, Serrao MP. High- and low-affinity transport of L-leucine and L-DOPA by the hetero amino acid exchangers LAT1 and LAT2 in LLC-PK1 renal cells. Am J Physiol Renal Physiol. 2004;287:F252\u201361. doi: 10.1152\/ajprenal.00030.2004 .","journal-title":"Am J Physiol Renal Physiol"},{"key":"3586_CR23","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0896-6273(02)00827-9","volume":"35","author":"GM Kruger","year":"2002","unstructured":"Kruger GM, Mosher JT, Bixby S, Joseph N, Iwashita T, Morrison SJ. Neural crest stem cells persist in the adult gut but undergo changes in self-renewal, neuronal subtype potential, and factor responsiveness. Neuron. 2002;35:657\u201369.","journal-title":"Neuron"},{"key":"3586_CR24","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1242\/jcs.096040","volume":"125","author":"JM Cantor","year":"2012","unstructured":"Cantor JM, Ginsberg MH. CD98 at the crossroads of adaptive immunity and cancer. J Cell Sci. 2012;125:1373\u201382. doi: 10.1242\/jcs.096040 .","journal-title":"J Cell Sci"},{"key":"3586_CR25","doi-asserted-by":"publisher","first-page":"9700","DOI":"10.1074\/jbc.M115.704254","volume":"291","author":"LR Ballina de la","year":"2016","unstructured":"de la Ballina LR, Cano-Crespo S, Gonzalez-Munoz E, Bial S, Estrach S, Cailleteau L, et al. Amino acid transport associated to cluster of differentiation 98 heavy chain (CD98hc) is at the cross-road of oxidative stress and amino acid availability. J Biol Chem. 2016;291:9700\u201311. doi: 10.1074\/jbc.M115.704254 .","journal-title":"J Biol Chem"},{"key":"3586_CR26","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.ccr.2013.04.018","volume":"23","author":"E Letouze","year":"2013","unstructured":"Letouze E, Martinelli C, Loriot C, Burnichon N, Abermil N, Ottolenghi C, et al. SDH mutations establish a hypermethylator phenotype in paraganglioma. Cancer Cell. 2013;23:739\u201352. doi: 10.1016\/j.ccr.2013.04.018 .","journal-title":"Cancer Cell"},{"key":"3586_CR27","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1073\/pnas.0404852102","volume":"102","author":"CC Feral","year":"2005","unstructured":"Feral CC, Nishiya N, Fenczik CA, Stuhlmann H, Slepak M, Ginsberg MH. CD98hc (SLC3A2) mediates integrin signaling. Proc Natl Acad Sci U S A. 2005;102:355\u201360. doi: 10.1073\/pnas.0404852102 .","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3586_CR28","doi-asserted-by":"publisher","first-page":"24477","DOI":"10.1074\/jbc.M702877200","volume":"282","author":"GW Prager","year":"2007","unstructured":"Prager GW, Feral CC, Kim C, Han J, Ginsberg MH. CD98hc (SLC3A2) interaction with the integrin beta subunit cytoplasmic domain mediates adhesive signaling. J Biol Chem. 2007;282:24477\u201384. doi: 10.1074\/jbc.M702877200 .","journal-title":"J Biol Chem"},{"key":"3586_CR29","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1083\/jcb.200705090","volume":"178","author":"CC Feral","year":"2007","unstructured":"Feral CC, Zijlstra A, Tkachenko E, Prager G, Gardel ML, Slepak M, et al. CD98hc (SLC3A2) participates in fibronectin matrix assembly by mediating integrin signaling. J Cell Biol. 2007;178:701\u201311. doi: 10.1083\/jcb.200705090 .","journal-title":"J Cell Biol"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-016-3586-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-016-3586-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-016-3586-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T04:42:31Z","timestamp":1498365751000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-016-3586-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,29]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["3586"],"URL":"https:\/\/doi.org\/10.1007\/s00259-016-3586-z","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,29]]}}}